File size: 5,497 Bytes
f9417e8
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
80a2165
 
 
 
 
 
 
 
f9417e8
80a2165
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
---
dataset_info:
  features:
  - name: case_id
    dtype: string
  - name: cohort
    dtype: string
  - name: roi_index
    dtype: int32
  - name: split
    dtype: string
  - name: image
    dtype: image
  - name: nuclei_mask
    dtype: image
  - name: tissue_mask
    dtype: image
  - name: nuclei_count
    dtype: int32
  - name: nuclei_class_ids
    list: int32
  - name: tissue_class_ids
    list: int32
  - name: mpp
    dtype: float32
  - name: magnification
    dtype: int32
  splits:
  - name: train
    num_bytes: 381386223
    num_examples: 206
  download_size: 381439088
  dataset_size: 381386223
configs:
- config_name: default
  data_files:
  - split: train
    path: data/train-*
tags:
- medical
- histopathology
- melanoma
- segmentation
- h&e
license: cc0-1.0
pretty_name: PUMA  Melanoma Nuclei & Tissue Segmentation
---

# PUMA — Panoptic Segmentation of Nuclei and Tissue in Advanced Melanoma

H&E histopathology ROIs from advanced melanoma with expert nuclei **and** tissue
annotations. Mirror of the official Zenodo release for use in the MedOtter
benchmark suite.

> ⚠️ **This is the public training split only: 206 of the challenge's 310 ROIs.**
> The 104 test ROIs are embargoed until **2029-10-10** and are not public
> anywhere. Treat this as a single-split dataset.

## Contents

| | |
|---|---|
| ROIs | 206 (103 primary + 103 metastatic melanoma) |
| Image | 1024×1024 RGB, 40×, ~0.226 µm/px |
| Nuclei | 97,429 annotated, 10 classes |
| Tissue | 5 foreground classes + background |
| Splits | `train` only (see embargo note above) |
| Licence | **CC0 1.0** |

Source images are uncompressed RGBA TIFF with a constant-255 alpha channel;
the alpha is dropped here (verified constant across all 206 files) and pixels
are stored as lossless PNG.

## Label maps

**Tissue** (`tissue_mask`) — values follow the **challenge evaluation**
convention, i.e. what the PUMA leaderboard scores against:

| Value | Class |
|---|---|
| 0 | background (`tissue_white_background`, unpainted) |
| 1 | stroma |
| 2 | blood vessel |
| 3 | tumor |
| 4 | epidermis |
| 5 | necrosis |

⚠️ A **second official map exists** and disagrees: the organizers' QuPath
export script uses `tumor=1, stroma=2, epidermis=3, necrosis=4,
blood_vessel=5`. We use the evaluation convention because that is what the
leaderboard and published PUMA models use. We do, however, keep the QuPath
**paint order** (`tumor < stroma < epidermis < necrosis < blood_vessel`, later
wins), so the masks stay geometrically identical to the official exports.
In practice the order decides only ~0.001% of pixels.

**Nuclei** (`nuclei_mask`) — the single official map:

| Value | Class | | Value | Class |
|---|---|---|---|---|
| 1 | lymphocyte | | 6 | melanophage |
| 2 | tumor | | 7 | endothelium |
| 3 | stroma | | 8 | epithelium |
| 4 | plasma cell | | 9 | neutrophil |
| 5 | histiocyte | | 10 | apoptosis |

The challenge's Track 1 uses a 3-class collapse of this map
(`lymphocyte→1, tumor→2, all others→3`); Track 2 uses all 10.

## Fields

`case_id`, `cohort` (`primary`/`metastatic`), `roi_index`, `split`, `image`,
`nuclei_mask`, `tissue_mask`, `nuclei_count`, `nuclei_class_ids`,
`tissue_class_ids`, `mpp`, `magnification`.

`nuclei_class_ids` / `tissue_class_ids` list the classes actually present in
each ROI — useful because several classes are rare: **necrosis appears in only
9/206 ROIs**, epidermis in 28/206, neutrophil in 30/206. Sampling a handful of
ROIs at random will report zero for those classes.

## Instance-level annotation

Semantic masks merge touching nuclei of the same class. The original QuPath
GeoJSON files are therefore included verbatim at the repo root:

* `01_training_dataset_geojson_nuclei.zip`
* `01_training_dataset_geojson_tissue.zip`

Coordinates are in ROI pixel space (0–1024).

## Provenance & caveats

* Official source: [Zenodo record 15050523](https://zenodo.org/records/15050523)
  (v5, 2025-03-19). Earlier versions differ — **v1/v2 were CC BY 4.0**, v3+ are
  CC0; v3 dropped `metastatic_roi_103` (205 ROIs) and v5 restored a corrected
  copy. The paper cites the stale v3 DOI and the challenge page links v4.
* In the source archive, `training_set_metastatic_roi_103` uses a `.tiff`
  extension while all 205 others use `.tif``glob("*.tif")` silently drops it.
* The Zenodo description says "103 primary and 102 metastatic"; the archives
  actually contain **103 + 103** (verified).
* Ground truth is the expert tier: nuclei were initialised by a
  PanNuke-pretrained HoVer-Net, corrected by a medical expert, then reviewed and
  corrected by a dermatopathologist. Tissue was drawn manually throughout.
  Reported human ceiling: nuclei F1 0.857 (intra-observer) / 0.802 (inter);
  tissue Dice 0.90.
* Because the nuclei GT was *seeded* by a PanNuke-pretrained model, models
  pretrained on PanNuke may carry a mild prior advantage on boundary detail.
  This is model lineage, not data leakage.
* No patient/image overlap with PanNuke, MoNuSAC, NuCLS, CoNIC/Lizard, BCSS,
  Pan-Cancer-Nuclei-Seg, DSB2018 or TCGA-SKCM — PUMA is single-institution
  material and carries no cross-reference IDs.

## Citation

Schuiveling M, Liu H, Eek D, Breimer GE, Suijkerbuijk KPM, Blokx WAM, Veta M.
*A novel dataset for nuclei and tissue segmentation in melanoma with baseline
nuclei segmentation and tissue segmentation benchmarks.* GigaScience.
2025;14:giaf011. doi:10.1093/gigascience/giaf011

Dataset: doi:10.5281/zenodo.15050523 (CC0 1.0)